Our population-based study also found that the methylation levels of Insulin-like growth factor 2 (IGF2) and Tumor suppressor candidate 3 (TUSC3) in blood leukocytes were significantly increased ahead of clinical diagnosis, which may serve as early biomarkers for GC [16]. The gene discussed is IGF2; the disease is gastric cancer.